Timo Minssen (T Minssen)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

Nature biotechnology

Journal of law and the biosciences

Healthcare (Basel, Switzerland)

European journal of health law

Lund University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lund University

Sweden

Researcher in Quantum Law :: Faculty of Law

Publications

Mateo Aboy, Timo Minssen, Effy Vayena
Navigating the EU AI Act: implications for regulated digital medical products. NPJ digital medicine 7 (1) (2024)
Ante B V Pettersson, Rosa Maria Ballardini, Marc Mimler, Phoebe Li, Mika Salmi, Timo Minssen, Ian Gibson, Antti Aarni Mäkitie
Core Legal Challenges for Medical 3D Printing in the EU. Healthcare (Basel, Switzerland) 12 (11) (2024)
Ante B V Pettersson, Rosa Maria Ballardini, Marc Mimler, Phoebe Li, Mika Salmi, Timo Minssen, Ian Gibson, Antti Aarni Mäkitie
Core Legal Challenges for Medical 3D Printing in the EU. Healthcare (Basel, Switzerland) 12 (11) (2024)
Danielle M Pacia, Beatrice L Brown, Timo Minssen, Jonathan J Darrow
CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations. Journal of law and the biosciences 11 (1) (2024)
Johnathon Liddicoat, Ashleigh Hamidzadeh, Kathleen Liddell, Marco Schito, David Simon, Mateo Aboy, Timo Minssen
New government drug repurposing programs: Opportunities and uncertainties. Science translational medicine 16 (753) (2024)
Ross Walsh, Emma C Kearns, Alice Moynihan, Sara Gerke, Mindy Duffourc, Marcelo Corrales Compagnucci, Timo Minssen, Ronan A Cahill
Ethical perspectives on surgical video recording for patients, surgeons and society: systematic review. BJS open 7 (3) (2023)
Ross Walsh, Emma C Kearns, Alice Moynihan, Sara Gerke, Mindy Duffourc, Marcelo Corrales Compagnucci, Timo Minssen, Ronan A Cahill
Ethical perspectives on surgical video recording for patients, surgeons and society: systematic review. BJS open 7 (3) (2023)
Rosa Maria Ballardini, Marc Mimler, Timo Minssen, Mika Salmi
3D Printing, Intellectual Property Rights and Medical Emergencies: In Search of New Flexibilities. IIC; international review of industrial property and copyright law 53 (8) (2022)
Duncan Matthews, Timo Minssen, Ana Nordberg
Balancing Innovation, 'Ordre Public' and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law. European journal of health law 29 (3-5) (2022)
Santa Slokenberga, Timo Minssen, Ana Nordberg
Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives. European journal of health law 29 (3-5) (2022)
Louise C Druedahl, Sofia Kälvemark Sporrong, Timo Minssen, Hans Hoogland, Marie Louise De Bruin, Marco van de Weert, Anna Birna Almarsdóttir
Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution. PloS one 17 (1) (2022)
Yann Joly, Gratien Dalpé, Charles Dupras, Bénédicte Bévière-Boyer, Aisling de Paor, Edward S Dove, Palmira Granados Moreno, Calvin W L Ho, Chih-Hsing Ho, Katharina Ó Cathaoir, Kazuto Kato, Hannah Kim, Lingqiao Song, Timo Minssen, Pilar Nicolás, Margaret Otlowski, Anya E R Prince, Athira P S Nair, Nozomi Mizushima, Torsten H Voigt, Chisato Yamasaki, Yvonne Bombard
Establishing the International Genetic Discrimination Observatory. Nature genetics 52 (5) (2020)
Ana Nordberg, Timo Minssen, Oliver Feeney, Iñigo De Miguel Beriain, Lucia Galvagni, Kirmo Wartiovaara
Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective. Bioethics 34 (1) (2020)
Sara Gerke, Ariel Dora Stern, Timo Minssen
Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries. NPJ digital medicine 3 (2020)
Louise C Druedahl, Anna Birna Almarsdóttir, Sofia Kälvemark Sporrong, Marie Louise De Bruin, Hans Hoogland, Timo Minssen, Marco van de Weert, Aaron S Kesselheim, Ameet Sarpatwari
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. Nature biotechnology 38 (11) (2020)
Mateo Aboy, Cristina Crespo, Kathleen Liddell, Neil Davey, Johnathon Liddicoat, Timo Minssen
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? Nature biotechnology 38 (3) (2020)
Hrefna D Gunnarsdóttir, M S Sinha, S Gerke, Timo Minssen
Applying the proportionality principle to COVID-19 antibody testing. Journal of law and the biosciences 7 (1) (2020)
R Neethu, Timo Minssen
What lurks in the shadows of the openness hyperbole for biopharmaceuticals? Drug development research 80 (3) (2019)
Mateo Aboy, Kathleen Liddell, Cristina Crespo, I Glenn Cohen, Johnathon Liddicoat, Sara Gerke, Timo Minssen
How does emerging patent case law in the US and Europe affect precision medicine? Nature biotechnology 37 (10) (2019)
Ana Nordberg, Timo Minssen, Sune Holm, Maja Horst, Kell Mortensen, Birger Lindberg Møller
Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns. Journal of law and the biosciences 5 (1) (2018)
W Nicholson Price, Timo Minssen
Will clinical trial data disclosure reduce incentives to develop new uses of drugs? Nature biotechnology 33 (7) (2016)

Timo Minssen.css-eqlu8i{font-size:small;padding-left:4px;} (T Minssen)

Publication Activity (10 Years)

Top Topics

Top Venues

Timo Minssen (T Minssen)